(Q36762112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Nieminen T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Lehtimäki T

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mäenpää J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ropo A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Uusitalo H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Clinical and Laboratory Investigation

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

237-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Pharmacogenomics and drug response in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Beta-blocker eyedrops and nocturnal arterial hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

A comparison of timolol and propranolol in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Timolol: a preliminary report of its pharmacological properties and therapeutic efficacy in angina and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Timolol metabolism and debrisoquine oxidation polymorphism: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601034736

10.1080/00365510601034736

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17366003%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference